Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

Scott M. Wilhelm, Lila Adnane, Philippa Newell, Augusto Villanueva, Josep M. Llovet, Mark Lynch

Research output: Contribution to journalReview articlepeer-review

1123 Scopus citations

Fingerprint

Dive into the research topics of 'Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling'. Together they form a unique fingerprint.

Medicine & Life Sciences